These findings indicate a potential trend toward increased PTEN and INPP4B mutations in H/L patients, but, given low mutation frequencies and a lack of statistical significance, larger studies are needed to assess the role of PI3K pathway alterations in HCC across ethnic groups. This evidence concerns the gene INPP4B and hepatocellular carcinoma.